Drug Channels

APRIL 2, 2025

Minnesota just released the industrys first ever mandated financial report on the 340B Drug Pricing Program. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here to see the original post from December 2024. I suspect similar reports are gonna be popular.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

OCTOBER 27, 2021

PBMs are conjuring a terrifying number of formulary exclusions for oncology drugs Eerie! Scream as Blue Cross Blue Shield frightfully overpays hospitals Shocking! drug spending shambles into the middle of the herd Plus, The Onion summons the only humorous article about CRISPR. d/b/a Drug Channels Institute.

Biosimilars 75

Biosimilars Hospitals Independent Pharmacies Drug Pricing 75

Drug Channels

AUGUST 18, 2020

Hospitals and health systems are building a major presence in the specialty pharmacy industry. As we demonstrate below, nine out of ten large hospitals now operate a specialty pharmacy. Hospitals and other healthcare providers account for one-third of all U.S. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing 52

Drug Channels

SEPTEMBER 24, 2023

Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. The difference between list prices and discounted 340B purchases also grew, to $52.3 The difference between list prices and discounted 340B purchases also grew, to $52.3 Hospitals accounted for 87% of 340B purchases for 2022.

Drug Pricing 96

Drug Pricing Hospitals 96

Drug Channels

OCTOBER 19, 2021

Hospitals and health systems are rapidly expanding their internal specialty pharmacies—and they’re using questionable tactics to boost revenues and profits. The 340B Drug Pricing Program’s explosive growth plays a crucial role in the economics of the health system specialty pharmacy channel. d/b/a Drug Channels Institute.

Specialty Pharmacies 96

Specialty Pharmacies Hospitals Drug Pricing 96

Drug Channels

DECEMBER 15, 2023

Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. The difference between list prices and discounted 340B purchases also grew, to $52.3 Hospitals accounted for 87% of 340B purchases for 2022. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. billion (+$2.6

Drug Pricing 98

Drug Pricing Hospitals 98

Drug Channels

AUGUST 6, 2024

You can also check out our recent data deep dive: Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy Restrictions: DCI's 2024 Market Analysis. © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here if you can’t see the video below. All rights reserved.

Drug Pricing 90

Drug Pricing Documentation Hospitals 90

Drug Channels

APRIL 1, 2024

The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. Below, I walk through the economic fundamentals to help you understand another obscure aspect of our opaque drug pricing system.

Drug Pricing 98

Drug Pricing Hospitals 98

Drug Channels

JULY 12, 2022

Despite what you may have heard, pharmacy participation in the 340B Drug Pricing Program continues to thrive. Drug Channels Institute’s latest analysis reveals that an astonishing 32,000 pharmacy locations —more than half of the entire U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Drug Pricing 98

Drug Pricing Hospitals 98

Drug Channels

JUNE 12, 2024

Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. Fein, Ph.D., All rights reserved.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

OCTOBER 2, 2024

Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. Fein, Ph.D., All rights reserved.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

JULY 27, 2021

In this issue: The top 10 stingiest hospitals Medicare Part B's savings from biosimilars What happened to hepatitis C drug costs and rebates? Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Biosimilars 52

Biosimilars Hospitals Drug Pricing 52

Drug Channels

NOVEMBER 9, 2022

Read on for full details on pricing and registration. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 98

Drug Channels

JULY 23, 2020

The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commercial insurance and Medicare Part D are footing the bill for 340B savings. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

SEPTEMBER 8, 2021

Read on for full details on pricing and registration. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Fein will give participants an opportunity to unmute themselves and ask live questions.

Drug Pricing 97

Drug Pricing Biosimilars Hospitals 97

Drug Channels

JULY 11, 2023

Looks like pharmacy and PBM profiteering within the 340B Drug Pricing Program will never go out of style. Drug Channels Institute’s (DCI) latest analysis reveals that more than 33,000 pharmacy locations —more than half of the entire U.S. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Hospitals 74

Hospitals Drug Pricing 74

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Specialty Pharmacies 75

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 75

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Drug Pricing 75

Drug Pricing Biosimilars Hospitals 75

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Specialty Pharmacies 75

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 75

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Drug Pricing 74

Drug Pricing Biosimilars Hospitals 74

Drug Channels

JUNE 8, 2021

That means it’s time to update Drug Channels Institute’s (DCI) annual analysis of pharmacist salaries and employment. We have found that the share of pharmacists who work at hospitals reached a new high. The 340B Drug pricing Program is a crucial topic for pharmacists. d/b/a Drug Channels Institute. to 1:30 p.m.

Hospitals 40

Hospitals Physician Offices Drug Pricing 40

Drug Channels

NOVEMBER 22, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Specialty Pharmacies 75

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 75

Drug Channels

JANUARY 20, 2021

I examine the growth rates of major spending categories, break down costs vs. utilization, and highlight the unfavorable out-of-pocket dynamics for prescription drugs compared with hospital care. Regular readers know the unofficial motto of Drug Channels : "Everyone is entitled to their own opinion, but not their own facts."

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

JUNE 15, 2021

Drug Channels Institute’s latest review of contract pharmacies in the 340B Drug Pricing Program reveals that an astonishing 30,000 pharmacy locations—half of the entire U.S. pharmacy industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

NOVEMBER 4, 2020

ICYMI, House Energy and Commerce Committee Republican Leader Greg Walden (R-OR) and Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Lamar Alexander (R-TN) recently asked for input on how to improve the 340B Drug Pricing Program. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. I shared my $0.02

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

MARCH 15, 2022

drug pricing, reimbursement, and dispensing system. Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. The 2022 Economic Report on U.S. The chart below illustrates the depth and breadth of the 2022 edition.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Drug Channels

JULY 21, 2020

pharmacies now participate in the 340B Drug Pricing Program. Hospitals are the primary 340B covered entities that engage with these specialty pharmacies. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Documentation Hospitals 52

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Hospitals 52

Drug Channels

JULY 14, 2020

It’s time for our annual look at the 340B Drug Pricing Program’s booming pharmacy component. industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

MARCH 26, 2021

ICYMI, House Energy and Commerce Committee Republican Leader Greg Walden (R-OR) and Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Lamar Alexander (R-TN) recently asked for input on how to improve the 340B Drug Pricing Program. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. I shared my $0.02

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

SEPTEMBER 2, 2020

However, Lilly will permit its insulin to be dispensed from 340B contract pharmacies—as long as patients receive the discounted 340B prices of $0.03 It’s time for our annual look at the 340B Drug Pricing Program’s booming pharmacy component. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. per 10 mL vial.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

SEPTEMBER 15, 2020

Last Friday, The Wall Street Journal published my opinion piece: The Federal Program That Keeps Insulin Prices High. I summarize issues with the role of contract pharmacies in the 340B Drug Pricing Program. My arguments will be familiar to regular readers of Drug Channels. d/b/a Drug Channels Institute.

Drug Pricing 40

Drug Pricing Hospitals 40

Drug Channels

FEBRUARY 23, 2021

Let’s melt away this foul February with our monthly selection of scorching news from around the drug channel. In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Click to Enlarge].

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Independent Pharmacies Online Pharmacies 52

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 40

Drug Channels

SEPTEMBER 22, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. Despite what you may have heard, the 340B Drug Pricing Program continues to thrive. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drug Pricing 45

Drug Pricing Hospitals 45

Drug Channels

DECEMBER 16, 2020

Last Friday, The Wall Street Journal published my opinion piece: The Federal Program That Keeps Insulin Prices High. I summarize issues with the role of contract pharmacies in the 340B Drug Pricing Program. My arguments will be familiar to regular readers of Drug Channels. d/b/a Drug Channels Institute.

Drug Pricing 40

Drug Pricing Hospitals 40

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. The video is excerpted from my recent Drug Channels Update: 340B Controversies and Outlook video webinar. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Hospitals 40